Covington & Burling represented Siris Capital Group, LLC in the transaction. Equiniti Group plc (EQ), a portfolio company of Siris Capital Group, LLC, announced its entry...
Equinitis’ $534.5 Million Acquisition of Notified
Novo Nordisk’s $1.3 Billion Acquisition of Ocedurenone
KBP Biosciences was represented by Goodwin Procter LLP and Novo Nordisk was represented by Covington & Burling LLP in this transaction. Novo Nordisk A/S and KBP...